Table 3.
Model 1b |
Model 2c |
Model 3d |
||||
---|---|---|---|---|---|---|
β | 95% CI | β | 95% CI | β | 95% CI | |
Mean uric acid concentration | ||||||
Category of diabetes duration, years | ||||||
0.0–4.3 (n = 378) | 1 | Reference | 1 | Reference | 1 | Reference |
4.4–7.2 (n = 377) | −0.29 | −0.50, −0.08 | −0.15 | −0.34, 0.03 | −0.09 | −0.27, 0.10 |
7.3–9.0 (n = 467) | −0.55 | −0.75, −0.35 | −0.36 | −0.54, −0.18 | −0.16 | −0.34, 0.02 |
9.1–65.0 (n = 288) | −0.52 | −0.75, −0.30 | −0.49 | −0.69, −0.29 | −0.27 | −0.47, −0.06 |
P-trende | <0.001 | <0.001 | 0.01 | |||
Continuous diabetes duration (per 5 years) | −0.15 | −0.21, −0.09 | −0.15 | −0.20, −0.09 | −0.10 | −0.15, −0.04 |
Mean 9-year within-person change in uric acid concentration | ||||||
Category of diabetes duration, years | ||||||
0.0–4.3 (n = 378) | 1 | Reference | 1 | Reference | 1 | Reference |
4.4–7.2 (n = 377) | −0.42 | −0.63, −0.21 | −0.37 | −0.58, −0.17 | −0.32 | −0.52, −0.11 |
7.3–9.0 (n = 467) | −0.68 | −0.88, −0.48 | −0.61 | −0.81, −0.41 | −0.42 | −0.62, −0.22 |
9.1–65.0 (n = 288) | −0.04 | −0.27, 0.19 | −0.06 | −0.28, 0.17 | 0.16 | −0.08, 0.39 |
P-trende | 0.32 | 0.27 | 0.30 | |||
Mean 9-year change (per 5 years with diabetes) | −0.01 | −0.08, 0.05 | −0.03 | −0.09, 0.03 | 0.02 | −0.04, 0.08 |
Abbreviation: CI, confidence interval.
a This analysis was conducted among visit 4 participants who had a visit-based diagnosis of diabetes by visit 4.
b Results were adjusted for age, sex, and race/study center.
c Results were adjusted for model 1 variables plus low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, body mass index, estimated glomerular filtration rate, hypertension, parental family history of diabetes, education, smoking status, alcohol use, and diuretic use.
d Results were adjusted for model 2 variables plus fasting glucose and fasting insulin levels.
e P-trend was calculated using the median value of each quartile to construct an ordinal variable.